Epilepsy
Conditions
Interventions
Sponsors
Department of Biofunctional Imaging, Hamamatsu University School of Medicine
Hamamatsu Medical Photonics Foundation NHO, National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders Hamamatsu Photonics
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Healthy participants aged 18 to 75 years 2. Individuals who have no history of psychiatric and neurological disease 3. Individuals who are consent to participate in this study 4. Patients with epilepsy (aged 18 to 75 years)
Exclusion criteria
Exclusion criteria: 1. Individuals who are suspected pregnant, pregnant or breast-feeding. 2. Individuals who have a history of claustrophobia. 3. Individuals who are considered unsuitable by doctors in charge. 4. Individuals with undergoing diabetes treatments who have the blood glucose level over 190mg/dl before PET examination. In other day, less than 190mg/dl is enable.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Elucidation of pathophysiology of epilepsy by examining the binding of [18F]BCPP-EF and [11C]DPA713PET tracers between epilepsy and normal control group. | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation of the PET tracer binding with clinical information, electroencephalogram, neuroimaging examinations and psychological date. | — |
Countries
Japan
Contacts
Public ContactYasuomi Ouchi
Hamamatsu University School of Medicine Department of Biofunctional Imaging
Outcome results
None listed